Photo coming soon
Tesamorelin
Shipping and payment
Chemistry & specifications
Reference data from public databases. For research use only.
| CAS Number | 218949-48-5 |
|---|---|
| Molecular Formula | C221H366N72O67S |
| Molecular Weight | 5136 g/mol |
| Residue Count | 44 |
| Sequence (1-letter) | YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL |
| PubChem CID | 16137828 → |
Common questions
What pack sizes and strengths are available for Tesamorelin?
Tesamorelin is offered as a 3-vial kit, a single vial, or a 10-vial box. Available strengths: 5 mg, 10 mg, 15 mg, and 20 mg per vial. Every vial in a kit or box is the strength you select. The price per vial for each pack is shown under the price.
How quickly does Tesamorelin ship?
Tesamorelin in 10 mg ships the same day when you order Monday to Friday before 3:00 PM Pacific. Orders after the cutoff, on weekends, or on US federal holidays ship the next business day, and never later than 2 business days after the order. The 5 mg, 15 mg, and 20 mg strengths are prepared to order and dispatched within 7 business days. Carrier transit then takes up to 3 business days within the contiguous United States. Standard shipping is a $18.99 flat rate and free on orders over $200.
How should Tesamorelin be stored?
Lyophilized (freeze-dried) vials tolerate normal shipping at room temperature. On arrival, keep them sealed, dry and away from light: a refrigerator at about 4 °C for the short term, or −20 °C or colder for long-term storage. Let a cold vial reach room temperature before opening it so moisture does not condense on the powder.
How do I work out the concentration after reconstitution?
Concentration in mg/mL equals the vial amount in mg divided by the mL of solvent added. Our free reconstitution calculator also shows the mg held at each 0.1 mL mark.
Is Tesamorelin for human use?
No. Tesamorelin is sold strictly for laboratory research use. It is not a drug, food, dietary supplement, or cosmetic, has not been evaluated by the FDA, and is not for human or veterinary use. Purchasers must be 21 or older.
Research background
Chemistry, identity, and a summary of the peer-reviewed literature on Tesamorelin.
Read the Tesamorelin research background → Reconstitution calculator →Peer-reviewed research
Every research claim on this page traces to one of the 4 publications below.
- Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extensionJ Acquir Immune Defic Syndr (2010)View publication →
- Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension dataJ Clin Endocrinol Metab (2010)View publication →
- Tesamorelin: a review of its use in the management of HIV-associated lipodystrophyDrugs (2011)View publication →
- Tesamorelin, a human growth hormone releasing factor analogueExpert Opin Investig Drugs (2009)View publication →



